Italy · biotech/health

Newronika

Newronika restores brain and body functions with innovative technologies.

PrivateFor profit

biotech/healthMilan, Italy

Against its peers

Set against 621 biotech/health companies worldwide. The ring marks the typical peer.

Staff11-50The typical size for its peers
Founded20087 years before the typical peer (2015)
Website traffic#10.3MQuieter than the typical peer's site (#4.6M)

Across all 5.9M companies: larger than 33% of those with a size listed; older than 40% of those with a founding year; website ranked #10,326,576 in the world, about 234 visits a month.

About Newronika

What it does

BioinformaticsBiotechnologyHealth CareHospitalMedical Device

Funding, as listed

What the source datasets report. We have not watched these rounds ourselves.

$13M

raised in total, currency not stated across 4 rounds

Last raised Dec 2022, 3 years ago

Rounds
4
Latest round
Grant
Investors
74 leading

Key facts

Who started it and how it trades.

Founded by
Alberto Priori, Lorenzo Rossi

Every detail we hold

Everything the source datasets list about Newronika, field by field. Contact details are held but never shown.

The company7 fields

Name
Newronika
Type
For profit
Status
Private
Founded
2008
Founders
Alberto Priori, Lorenzo Rossi
Industry
biotech/health
Categories
Bioinformatics, Biotechnology, Health Care, Hospital, Medical Device

Where3 fields

City
Milan
Country
Italy
Markets
European Union (EU), Europe, Middle East, and Africa (EMEA)

Size and reach3 fields

Staff band
11-50
Web traffic rank
#10,326,576
Monthly web visits
234
Show 9 more fieldsShow fewer fields

Funding, as listed7 fields

Total
12,600,000 (currency not stated)
Rounds
4
Latest round
Grant
Latest round date
Dec 2022
Investors
7
Lead investors
4
Listing status
private

About this record2 fields

Sources
crunchbase,site-facts
Last imported
Sept 2026

Companies like Newronika

biotech/health in Italy.

Build a lead list

Every biotech/health company, filtered by size, age and reach, ready to export with emails on Pro.

Open the list